Case Report: AL Amyloidosis Severe Restrictive Cardiomyopathy Associated With Multiple Myeloma—Diagnostic Difficulties

Case Report: AL Amyloidosis Severe Restrictive Cardiomyopathy Associated With Multiple Myeloma—Diagnostic Difficulties

BackgroundCardiac AL amyloidosis as a complication of multiple myeloma (MM) is a formidable life-threatening condition. The first-line therapy for both MM and systemic AL amyloidosis is proteasome inhibitors (PIs). Unfortunately, the use of PIs may lead to cardiovascular toxicity development, which...

Full description

Bibliographic Details
Main Authors: Yulia Y. Kirichenko, Irina S. Ilgisonis, Elena S. Nakhodnova, Irina Y. Sokolova, Olga V. Bochkarnikova, Sabina A. Kardanova, Olga V. Lyapidevskaya, Elena V. Privalova, Vladimir I. Ershov, Yurii N. Belenkov
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
multiple myeloma
cardiotoxicity
vasculotoxicity
cardiac amyloidosis
restrictive cardiomyopathy (RCM)
speckle tracking ECHO
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.862409/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.862409/full

Similar Items